Vaccinex Inc. (VCNX)

1.10

-0.04 (-3.51%)

At close: Feb 28, 2025, 11:48 AM

1.34

21.41%

After-hours: Dec 17, 2024, 07:43 PM EST

Vaccinex Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-20.25M	-19.82M	-22.38M	-28.85M	-31.86M	-29.52M	-18.76M	-13.94M
Depreciation & Amortization	119K	207K	169K	307K	249K	223K	206K	178K
Stock-Based Compensation	474K	545K	541K	732K	447K	177K	319K	135K
Other Working Capital	583K	-293K	-1.26M	-1.93M	31K	-298K	298K	-2.33M
Other Non-Cash Items	2.11M	677K	458K	297K	-44K	308K	1.22M	1.57M
Deferred Income Tax	n/a	-677K	-876K	-65K	n/a	1.91M	-3.74M	-9.31M
Change in Working Capital	318K	-11K	-3.21M	-1.07M	496K	1.62M	-627K	1.65M
Operating Cash Flow	-17.23M	-19.07M	-25.3M	-28.65M	-30.71M	-25.28M	-21.39M	-19.72M
Capital Expenditures	-67K	-99K	-32K	-290K	-78K	-235K	-68K	-793K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-20.76M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	14.15M	6.75M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	14.15M	-14.01M	n/a	n/a
Investing Cash Flow	-67K	-99K	-32K	-290K	14.07M	-14.24M	-68K	-793K
Debt Repayment	-74K	-75K	-8.54M	9.03M	n/a	-5.5M	3.98M	5.68M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-985K	-744K	n/a	9.33M	20M	21.36M
Financial Cash Flow	12.45M	16.98M	23.32M	36.76M	13.8M	40.95M	23.97M	16.36M
Net Cash Flow	-4.86M	-2.2M	-2.01M	7.82M	-2.84M	1.44M	2.52M	-4.16M
Free Cash Flow	-17.3M	-19.17M	-25.33M	-28.94M	-30.79M	-25.51M	-21.45M	-20.51M